Zoetis (NYSE:ZTS) Shares Up 3%

Shares of Zoetis Inc. (NYSE:ZTS - Get Free Report) traded up 3% during trading on Tuesday . The company traded as high as $172.23 and last traded at $170.88. 776,706 shares traded hands during trading, a decline of 75% from the average session volume of 3,148,847 shares. The stock had previously closed at $165.95.

Analyst Ratings Changes

Several research analysts have recently issued reports on ZTS shares. Stifel Nicolaus lowered their price objective on Zoetis from $195.00 to $180.00 and set a "buy" rating for the company in a research note on Tuesday, April 30th. Barclays cut their price target on shares of Zoetis from $260.00 to $230.00 and set an "overweight" rating on the stock in a report on Tuesday, April 23rd. The Goldman Sachs Group decreased their price objective on Zoetis from $223.00 to $196.00 and set a "buy" rating for the company in a report on Monday. StockNews.com downgraded Zoetis from a "strong-buy" rating to a "buy" rating in a report on Tuesday, February 20th. Finally, Piper Sandler reissued an "overweight" rating and issued a $195.00 price target (down previously from $220.00) on shares of Zoetis in a research note on Tuesday, April 16th. Eight investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $212.38.

Zoetis Price Performance

The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.94 and a current ratio of 3.33. The business has a 50 day moving average price of $167.64 and a 200-day moving average price of $178.93. The company has a market capitalization of $76.86 billion, a price-to-earnings ratio of 32.46, a P/E/G ratio of 2.62 and a beta of 0.86.

Zoetis (NYSE:ZTS - Get Free Report) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $1.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.34 by $0.04. The firm had revenue of $2.19 billion for the quarter, compared to analyst estimates of $2.14 billion. Zoetis had a return on equity of 50.34% and a net margin of 27.38%. The company's revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.31 earnings per share. Research analysts predict that Zoetis Inc. will post 5.77 EPS for the current fiscal year.

Insider Buying and Selling at Zoetis

In other news, EVP Roxanne Lagano sold 923 shares of the stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $173.33, for a total transaction of $159,983.59. Following the transaction, the executive vice president now owns 15,723 shares of the company's stock, valued at approximately $2,725,267.59. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Over the last ninety days, insiders sold 2,209 shares of company stock valued at $371,293. Corporate insiders own 0.16% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Hohimer Wealth Management LLC grew its position in Zoetis by 1.2% in the 4th quarter. Hohimer Wealth Management LLC now owns 4,386 shares of the company's stock valued at $866,000 after purchasing an additional 52 shares during the period. Forum Financial Management LP raised its stake in shares of Zoetis by 0.8% during the 4th quarter. Forum Financial Management LP now owns 7,386 shares of the company's stock valued at $1,458,000 after purchasing an additional 56 shares during the period. Angeles Wealth Management LLC lifted its holdings in Zoetis by 3.5% during the 4th quarter. Angeles Wealth Management LLC now owns 1,640 shares of the company's stock worth $324,000 after purchasing an additional 56 shares in the last quarter. Prossimo Advisors LLC boosted its stake in Zoetis by 1.7% in the 4th quarter. Prossimo Advisors LLC now owns 3,498 shares of the company's stock worth $690,000 after purchasing an additional 57 shares during the period. Finally, River Street Advisors LLC increased its position in shares of Zoetis by 3.4% during the fourth quarter. River Street Advisors LLC now owns 1,757 shares of the company's stock valued at $347,000 after buying an additional 58 shares during the period. Institutional investors own 92.80% of the company's stock.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.